Autonome Small-Fiber-Neuropathien

In diesem Beitrag werden die wichtigsten Erkrankungen skizziert, die ätiologisch einer Small-Fiber-Neuropathie (SFN) zugrunde liegen können. Schwerpunkt des Artikels bildet die Charakterisierung der im klinischen Alltag bereits etablierten sowie der in der aktuellen klinischen Forschung untersuchten Verfahren zur Diagnostik einer kutanen autonomen Dysfunktion.

Schlüsselwörter

Haut - autonomes Nervensystem - sudomotorisch - vasomotorisch - QSART

• Literatur

• 1 Siepmann T, Penzlin A, Illigens B. Formen autonomer Nervenkrankheiten. Dtsch Med Wochenschr 2013; 138: 1465-1469
• 2 Langlois V, Bedat AM, Lebesnerais M. et al. Small fiber neuropathy. Rev Med Interne 2018; 39: 99-106
• 3 Freeman R. Autonomic peripheral neuropathy. Lancet 2005; 365: 1259-1270
• 4 Siepmann T, Penzlin A, Illigens B. Autonomic neuropathies. Dtsch Med Wochenschr 2013; 138: 1465-1469
• 5 Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes 2014; 5: 17
• 6 Siepmann T, Illigens B-W, Reichmann H. et al. Axon-Reflex-basierte Nervenmessverfahren in der Diagnostik autonomer Neuropathie. Nervenarzt 2014; 85: 1309-1314
• 7 Siepmann T, Penzlin A, Illigens B. Autonome Nervenkrankheiten – Früherkennung und leitliniengerechte Behandlung. Dtsch Med Wochenschr 2013; 138: 1529-1532
• 8 Eschlböck S, Wenning G, Fanciulli A. Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms. J Neural Transmission 2017; 124: 1567-1605
• 9 Serhiyenko VA, Serhiyenko AA. Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment. World J Diabetes 2018; 9: 1-24
• 10 Axelrod FB, Gold-von Simson G. Hereditary sensory and autonomic neuropathies: types II, III, and IV. Orphanet J Rare Dis 2007; 2: 39
• 11 Misgar RA, Pala NA, Ramzan M. et al. Allgrove (triple a) syndrome: a case report from the Kashmir Valley. Endocrinol Metab 2015; 30: 604-606
• 12 Nagappa M, Taly AB, Mahadevan A. et al. Tangierʼs disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy. Ann Indian Acad Neurol 2016; 19: 137-139
• 13 Köping M, Shehata-Dieler W, Cebulla M. et al. Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease. PLoS One 2017; 12: e0188103
• 14 Znaczko A, Donnelly DE, Morrison PJ. Epidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete population. Oncologist 2014; 19: 1284-1286
• 15 Sipe JD, Benson MD, Buxbaum JN. et al. Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 2014; 21: 221-224
• 16 Berghoff M, Kathpal M, Kilo S, Hilz MJ, Freeman R. Vascular and neural mechanisms of ACh-mediated vasodilation in the forearm cutaneous microcirculation. J Applied Physiology 2002; 92: 780-788
• 17 Kilo S, Berghoff M, Hilz M, Freeman R. Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy. Neurology 2000; 54: 1246-1252
• 18 Kubasch ML, Kubasch AS, Torres Pacheco J. et al. Laser doppler assessment of vasomotor axon reflex responsiveness to evaluate neurovascular function. Front Neurol 2017; 8: 370
• 19 Benarroch EE, Low PA. The acetylcholine‐induced flare response in evaluation of small fiber dysfunction. Ann Neurol 1991; 29: 590-595
• 20 Low PA, Neumann C, Dyck PJ. et al. Evaluation of skin vasomotor reflexes by using laser Doppler velocimetry. Mayo Clinic Proc 1983; 58: 583-592
• 21 Bickel A, Krämer H, Hilz M. et al. Assessment of the neurogenic flare reaction in small-fiber neuropathies. Neurology 2002; 59: 917-919
• 22 Green AQ, Krishnan ST, Rayman G. C‐fiber function assessed by the laser doppler imager flare technique and acetylcholine iontophoresis. Muscle Nerve 2009; 40: 985-991
• 23 Nouri MN, Ahmed A, Bril V. et al. Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes. PLoS One 2012; 7: e34807
• 24 Low PA, Caskey P, Tuck R. et al. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 1983; 14: 573-580
• 25 Low VA, Sandroni P, Fealey RD. et al. Detection of small‐fiber neuropathy by sudomotor testing. Muscle Nerve 2006; 34: 57-61
• 26 Illigens BM, Gibbons CH. Sweat testing to evaluate autonomic function. Clin Autonom Res 2009; 19: 79
• 27 Siepmann T, Pintér A, Buchmann SJ. et al. Cutaneous autonomic pilomotor testing to unveil the role of neuropathy progression in early Parkinsonʼs disease (CAPTURE PD): Protocol for a multicenter study. Front Neurol 2017; 8: 212
• 28 Siepmann T, Gibbons CH, Illigens BM. et al. Quantitative pilomotor axon reflex test: A novel test of pilomotor function. Arch Neurol 2012; 69: 1488-1492
• 29 Attal N, Cruccu G, Baron R. et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neur 2010; 17: 1113
• 30 Dworkin RH, OʼConnor AB, Audette J. et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85: S3-S14
• 31 Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; 150: 573-581